Emergency Preparedness Antibiotics
Titre original de l'avis
Sweden – Stock-control services – Beredskapsläkemedel - Antibiotika
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
40 / 100
Facteurs de risque
Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect compliance and reporting re...
Award criteria, eligibility criteria, and required documents are not provided in the notice, increasing uncertainty.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- Folkhälsomyndigheten
- Pays
- Suède
- CPV
- 79991000 - Stock-control services +1 autres
- Date limite
- Aug 18, 2026
- Valeur estimée
- SEK 20M (approx. EUR 1.8M)
Aperçu
Moderate opportunityFaits clés
- SEK 20M estimated value
- Services contract
- 1 lot
- Duration until Dec 2028
- Stock-control services for antibiotics.
- Maintain a revolving reserve stock for emergency preparedness.
Afficher le résumé complet
This tender by the Public Health Agency of Sweden (Folkhälsomyndigheten) seeks a supplier for stock-control services of antibiotics, requiring the supplier to maintain a revolving reserve stock for emergency preparedness. The contract is a non-framework service agreement with a planned duration from December 15, 2026, to December 31, 2028, with an option to extend up to two years. The estimated total value is SEK 20,000,000. The procedure is a negotiated procedure with call for competition, and submission is electronic via tendsign.com. The tender is restricted to pharmaceutical companies marketing antibiotics in Sweden.
Risques
Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect compliance and reporting re...
Award criteria, eligibility criteria, and required documents are not provided in the notice, increasing uncertainty.
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Supplier must be a pharmaceutical company marketing antibiotics in Sweden.
- Hold a revolving stock of specified volume reserved for the authority's emergency preparedness.
- Stock must be integrated into the normal product flow (revolving stock).
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Localisation
SOLNA, SWE
Site web
Identifiant
2021006545
Activité
Health
Lots (1)
LOT-0000
Emergency Preparedness Antibiotics
Procurement of various antibiotics, requiring the supplier to hold a revolving stock of specified volume reserved for the authority's emergency preparedness. The stock rotates as part of normal turnover.
EUR 1.8M
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Denna upphandling omfattar olika sorters antibiotika och vänder sig till läkemedelsföretag som marknadsför antibiotika i Sverige. Leverantören ska hålla ett omsättningslager med i avtal specificerad volym reserverat för myndighetens beredskap. Omsättningslager avser en form av lagerhållning där varor kontinuerligt byts ut i takt med förbrukningen och ingår som en del av det ordinarie varuflödet.
Codes CPV supplémentaires
Note sur la valeur
Afficher les données TED originales
Titre original du lot
Beredskapsläkemedel - Antibiotika
Description TED originale
Denna upphandling omfattar olika sorters antibiotika och vänder sig till läkemedelsföretag som marknadsför antibiotika i Sverige. Leverantören ska hålla ett omsättningslager med i avtal specificerad volym reserverat för myndighetens beredskap. Omsättningslager avser en form av lagerhållning där varor kontinuerligt byts ut i takt med förbrukningen och ingår som en del av det ordinarie varuflödet.
Détails de la procédure
- Date de publication
- 16 Jun 2026
- Langues
- Swedish
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 414672-2026
Documents (2)
Appels d'offres similaires
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
40 / 100
Facteurs de risque
Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect compliance and reporting re...
Award criteria, eligibility criteria, and required documents are not provided in the notice, increasing uncertainty.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications